scholarly journals Clifford Wavelet Entropy for Fetal ECG Extraction

Entropy ◽  
2021 ◽  
Vol 23 (7) ◽  
pp. 844
Author(s):  
Malika Jallouli ◽  
Sabrine Arfaoui ◽  
Anouar Ben Ben Mabrouk ◽  
Carlo Cattani
Keyword(s):  
Heart Rate ◽  
Fetal Heart Rate ◽  
Fetal Heart ◽  
Invasive Technique ◽  
Fetal Heart Rate Monitoring ◽  
Non Invasive ◽  
Heart Monitoring ◽  
Medical Issues ◽  
Fetal Ecg ◽  
Appl Math

Analysis of the fetal heart rate during pregnancy is essential for monitoring the proper development of the fetus. Current fetal heart monitoring techniques lack the accuracy in fetal heart rate monitoring and features acquisition, resulting in diagnostic medical issues. The challenge lies in the extraction of the fetal ECG from the mother ECG during pregnancy. This approach has the advantage of being a reliable and non-invasive technique. In the present paper, a wavelet/multiwavelet method is proposed to perfectly extract the fetal ECG parameters from the abdominal mother ECG. In a first step, due to the wavelet/mutiwavelet processing, a denoising procedure is applied to separate the noised parts from the denoised ones. The denoised signal is assumed to be a mixture of both the MECG and the FECG. One of the well-known measures of accuracy in information processing is the concept of entropy. In the present work, a wavelet/multiwavelet Shannon-type entropy is constructed and applied to evaluate the order/disorder of the extracted FECG signal. The experimental results apply to a recent class of Clifford wavelets constructed in Arfaoui, et al. J. Math. Imaging Vis. 2020, 62, 73–97, and Arfaoui, et al.Acta Appl. Math.2020, 170, 1–35.. Additionally, classical Haar–Faber–Schauder wavelets are applied for the purpose of comparison. Two main well-known databases have been applied, the DAISY database and the CinC Challenge 2013 database. The achieved accuracy over the test databases resulted in Se=100%, PPV=100% for FECG extraction and peak detection.

scholarly journals To compare intrapartum cardiotocographic (CTG) recording with conventional intermittent fetal heart auscultation during labor

2014 ◽  
Vol 2 (03) ◽  
pp. 76-79
Author(s):  
Isha Bansal ◽  
Richa Kansal ◽  
R. Mahendru ◽  
Sunita Siwach ◽  
Deepak Singla ◽  
...  
Keyword(s):  
Heart Rate ◽  
Fetal Heart Rate ◽  
Fetal Heart ◽  
Blood Gas Analysis ◽  
Well Being ◽  
Gas Analysis ◽  
Non Invasive ◽  
Fetal Ecg ◽  
Invasive Techniques ◽  
Heart Auscultation

Standard evaluation of fetal well-being during labor includes the periodic assessment of the fetal heart rate (FHR), its pattern and response to intrapartum stimuli and events. Effective methods of evaluation and meaningful interpretation of FHR data range from non-invasive techniques like Intermittent Auscultation, continuous electronic fetal heart rate (FHR) monitoring to invasive techniques of fetal blood gas analysis and fetal ECG.

scholarly journals Comparison of Cardiotocography and Fetal Heart Rate Estimators Based on Non-Invasive Fetal ECG

2019 ◽  
Author(s):  
Rasmus Gundorff Sæderup ◽  
Henrik Zimmermann ◽  
Dagbjört Helga Eiríksdóttir ◽  
John Hansen ◽  
Johannes Struijk ◽  
...  
Keyword(s):  
Heart Rate ◽  
Fetal Heart Rate ◽  
Fetal Heart ◽  
Non Invasive ◽  
Fetal Ecg

scholarly journals Harnessing technology to enable all women mobility in labour and birth: feasibility of implementing beltless non-invasive fetal ECG applying the NASSS framework

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Deborah Fox ◽  
Rebecca Coddington ◽  
Vanessa Scarf ◽  
Andrew Bisits ◽  
Anne Lainchbury ◽  
...  
Keyword(s):  
Heart Rate ◽  
Fetal Heart Rate ◽  
Fetal Heart ◽  
Fetal Monitoring ◽  
Trial Registration ◽  
Health Technologies ◽  
Freedom Of Movement ◽  
Non Invasive ◽  
Fetal Ecg ◽  
Loss Of Contact

Abstract Background A new wireless and beltless monitoring device utilising fetal and maternal electrocardiography (ECG) and uterine electromyography, known as ‘non-invasive fetal ECG’ (NIFECG) was registered for clinical use in Australia in 2018. The safety and reliability of NIFECG has been demonstrated in controlled settings for short periods during labour. As far as we are aware, at the time our study commenced, this was globally the first trial of such a device in an authentic clinical setting for the entire duration of a woman’s labour. Methods This study aimed to assess the feasibility of using NIFECG fetal monitoring for women undergoing continuous electronic fetal monitoring during labour and birth. Women were eligible to participate in the study if they were at 36 weeks gestation or greater with a singleton pregnancy, planning to give birth vaginally and with obstetric indications as per local protocol (NSW Health Fetal Heart Rate Monitoring Guideline GL2018_025. 2018) for continuous intrapartum fetal monitoring. Written informed consent was received from participating women in antenatal clinic prior to the onset of labour. This single site clinical feasibility study took place between January and July 2020 at the Royal Hospital for Women in Sydney, Australia. Quantitative and qualitative data were collected to inform the analysis of results using the NASSS (Non-adoption, Abandonment, Scale up, Spread and Sustainability) framework, a validated tool for analysing the implementation of new health technologies into clinical settings. Results Women responded positively about the comfort and freedom of movement afforded by the NIFECG. Midwives reported that when no loss of contact occurred, the device enabled them to focus less on the technology and more on supporting women’s physical and emotional needs during labour. Midwives and obstetricians noticed the benefits for women but expressed a need for greater certainty about the reliability of the signal. Conclusion The NIFECG device enables freedom of movement and positioning for labouring women and was well received by women and the majority of clinicians. Whilst measurement of the uterine activity was reliable, there was uncertainty for clinicians in relation to loss of contact of the fetal heart rate. If this can be ameliorated the device shows potential to be used as routinely as cardiotocography (CTG) for fetal monitoring. This is the first time the NASSS framework has been used to synthesise the implementation needs of a health technology in the care of women during labour and birth. Our findings contribute new knowledge about the determinants for implementation of a complex technology in a maternity care setting. Trial registration The Universal Trial Number is reU1111-1228-9845 and the Australian and New Zealand Clinical Trial Registration Number is 12619000293167p. Trial registration occurred on the 20 February, 2019. The trial protocol may be viewed at http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377027

Noninvasive fetal ECG mode fetal heart rate monitoring by adaptive digital filtering

1992 ◽  
Vol 20 (2) ◽  
pp. 93-100 ◽  
Author(s):  
Thomas H. Frank ◽  
Otis R. Blaumanis ◽  
Serena H. Chen ◽  
Roy H. Petrie ◽  
Richard K. Gibbs ◽  
...  
Keyword(s):  
Heart Rate ◽  
Fetal Heart Rate ◽  
Fetal Heart ◽  
Digital Filtering ◽  
Heart Rate Monitoring ◽  
Fetal Heart Rate Monitoring ◽  
Fetal Ecg

Extraction of Fetal ECG in a Non-invasive Way and Estimation of Fetal Heart Rate

2020 ◽  
Author(s):  
Md. Fazlul Karim Khondakar ◽  
Md Fazlul Karim Khondakar ◽  
Md Hasib Sarowar ◽  
Md. Hasib Sarowar ◽  
Quazi Delwar Hossain ◽  
...  
Keyword(s):  
Heart Rate ◽  
Fetal Heart Rate ◽  
Fetal Heart ◽  
Non Invasive ◽  
Fetal Ecg
Sign in / Sign up

Export Citation Format

Share Document